Trial Profile
Gemcitabine transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Dec 2015 New trial record